JAZZ - Jazz Pharmaceuticals plc

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 55.44B
Enterprise value 36.14B
Trailing P/E 10.67
Forward P/E 15.71
PEG ratio (5-yr expected) 11.13
Price/sales (ttm)2.52
Price/book (mrq)1.75
Enterprise value/revenue 32.84
Enterprise value/EBITDA 66.06

Trading information

Stock price history

Beta (5Y monthly) 1.34
52-week change 3-32.17%
S&P500 52-week change 3-11.36%
52-week high 3154.24
52-week low 386.88
50-day moving average 3118.54
200-day moving average 3132.96

Share statistics

Avg vol (3-month) 3673.22k
Avg vol (10-day) 3798.54k
Shares outstanding 556.57M
Float 51.07M
% held by insiders 12.80%
% held by institutions 196.85%
Shares short (12 Mar 2020) 43.17M
Short ratio (12 Mar 2020) 43.44
Short % of float (12 Mar 2020) 45.76%
Short % of shares outstanding (12 Mar 2020) 45.66%
Shares short (prior month 13 Feb 2020) 43.18M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)30 Dec 2019

Profitability

Profit margin 24.21%
Operating margin (ttm)32.25%

Management effectiveness

Return on assets (ttm)8.11%
Return on equity (ttm)17.84%

Income statement

Revenue (ttm)2.16B
Revenue per share (ttm)38.09
Quarterly revenue growth (yoy)22.10%
Gross profit (ttm)2.03B
EBITDA 1.01B
Net income avi to common (ttm)523.37M
Diluted EPS (ttm)9.09
Quarterly earnings growth (yoy)-53.60%

Balance sheet

Total cash (mrq)1.08B
Total cash per share (mrq)19.19
Total debt (mrq)1.77B
Total debt/equity (mrq)56.98
Current ratio (mrq)4.47
Book value per share (mrq)55.41

Cash flow statement

Operating cash flow (ttm)776.4M
Levered free cash flow (ttm)540.45M